NASDAQ:FULC
USD
5.41
- (6.7%)
FULCRUM THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 8 May 2025 GMT-4
USD 5.410
- (6.7%)
End of Day: 8 May 2025 GMT-4
Industry: Biotechnology
Quote
Market Cap
-
1M Daily Avg. Vol
-
3Y P/B Range
-
52W Range
-
3Y P/S Range
-
3Y DivYield Range
-
Company Info
more
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscula...
Key Ratios
more
Income
more
Total Revenues (USD, MM)
-
Net Income (USD, MM)
-
Net Margin
-
Balance Sheet
more
Total Assets (USD, MM)
-
Total Liabilities (USD, MM)
-
Book Value Per Share
-
Cash Flow
more
Operations (USD, MM)
-
Investing (USD, MM)
-
Financing (USD, MM)
-
Make Smart Investment Choices